Biotech

The last veterans of World War Two are dying. COVID-19 rhymed with the Spanish Flu. We are deep in a Fourth Turning crisis. And yet, by every measurable standard, this is the greatest time in human history to be alive. The future is not just inevitable — it is inevitably good.

An evidence-led, optimistic tour of biohacking: what it is, why the science is sound, and how the movement is converging with clinical longevity medicine of the kind practised at Bangkok's Target150.

Natural killer (NK) cells are the immune system’s first line of defense against cancer. This 2026 guide covers NK cell biology, how they destroy tumors, the latest CAR-NK and memory-like breakthroughs from Dana-Farber, MIT, Yale and McGill, and how to support your own NK cell function.

Three new economic layers are taking shape: space is becoming an industrial domain, artificial intelligence is evolving into continuous infrastructure, and quantum technologies are moving into operational use in simulation and sensing. While technical and energy constraints remain significant, the period through 2035 is likely to see these layers expand in parallel, creating new requirements for verifiable trust and post-quantum security. KXCO is positioning its infrastructure as the transaction

Saudi Arabia’s Public Investment Fund (PIF) manages over $900 billion. This analysis covers its investments by sector and geography, major project updates including Qiddiya and HUMAIN, and the 2026–2030 strategy.

Why screen? Silent processes like chronic inflammation (inflammaging), mitochondrial dysfunction, and senescent cell accumulation drive most age-related decline. Biolongevity screening uncovers these before symptoms appear, enabling proactive biohacking strategies